These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 14723002

  • 1. State-of-the-art treatment for advanced non-small-cell lung cancer.
    Sandler A.
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 13):15-22. PubMed ID: 14723002
    [Abstract] [Full Text] [Related]

  • 2. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
    Khuri FR.
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
    [Abstract] [Full Text] [Related]

  • 3. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F, Helsberg K, Schütte WH, Leschinger MI.
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [Abstract] [Full Text] [Related]

  • 4. First-line treatment for advanced non-small-cell lung cancer.
    Laskin JJ, Sandler AB.
    Oncology (Williston Park); 2005 Nov; 19(13):1671-6; discussion 1678-80. PubMed ID: 16425521
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I.
    Cas Lek Cesk; 2005 Nov; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [Abstract] [Full Text] [Related]

  • 6. Current management of unresectable non-small cell lung cancer.
    Livingston RB.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [Abstract] [Full Text] [Related]

  • 7. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies.
    Gordon GS, Vokes EE.
    Oncology (Williston Park); 1999 Aug; 13(8):1075-88; discussion 1088, 1091-4. PubMed ID: 10499243
    [Abstract] [Full Text] [Related]

  • 8. Docetaxel for previously treated non-small-cell lung cancer.
    Fossella FV.
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):45-51. PubMed ID: 12108897
    [Abstract] [Full Text] [Related]

  • 9. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
    Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Belani CP.
    J Clin Oncol; 2003 Aug 15; 21(16):3016-24. PubMed ID: 12837811
    [Abstract] [Full Text] [Related]

  • 10. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy in metastatic and locally advanced non-small cell lung cancer.
    Spigel DR, Greco FA.
    Semin Surg Oncol; 2003 Apr 10; 21(2):98-110. PubMed ID: 14508860
    [Abstract] [Full Text] [Related]

  • 12. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb 10; 14(75):16-8. PubMed ID: 15751170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
    Bunn PA.
    Anticancer Drugs; 2001 Jul 10; 12 Suppl 3():S3-8. PubMed ID: 11556251
    [Abstract] [Full Text] [Related]

  • 16. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA.
    Semin Oncol; 1998 Aug 10; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [Abstract] [Full Text] [Related]

  • 17. The future beyond platinum for the treatment of advanced non-small cell lung cancer.
    Dragnev KH, Rigas JR.
    Semin Oncol; 1999 Oct 10; 26(5 Suppl 16):73-6. PubMed ID: 10585012
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan.
    Langer CJ.
    Oncology (Williston Park); 2001 Jan 10; 15(1 Suppl 1):19-24. PubMed ID: 11221017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.